Rapid quantification of levosulpiride in human plasma using RP-HPLC-MS/MS for pharmacokinetic and bioequivalence study.
Substance Nomenclature: | 0 (Dopamine Antagonists) 7MNE9M8287 (Sulpiride) JTG7R315LK (levosulpiride) |
---|---|
Entry Date(s): | Date Created: 20090603 Date Completed: 20100209 Latest Revision: 20191210 |
Update Code: | 20240829 |
DOI: | 10.1002/bmc.1260 |
PMID: | 19488984 |
Autor: | Park JH; Department of Pharmacology and Institute of Biomedical Sciences, College of Medicine, Hanyang University, Seoul, South Korea., Park YS, Rhim SY, Kim HJ, Jhee OH, Lee YS, Lee MH, Shaw LM, Kang JS |
Jazyk: | angličtina |
Zdroj: | Biomedical chromatography : BMC [Biomed Chromatogr] 2009 Dec; Vol. 23 (12), pp. 1350-6. |
DOI: | 10.1002/bmc.1260 |
Abstrakt: | A rapid and validated method for analysis of levosulpiride in human plasma using liquid chromatography coupled to tandem mass spectrometry was developed. Levosulpiride and tiapride (IS, internal standard) were extracted from alkalized plasma samples with ethylacetate and separation by RP-HPLC. Detection was performed by positive ion electrospray ionization in multiple-reaction monitoring mode, monitoring the transitions m/z 342.1 --> m/z 112.2 and m/z 329.1 --> m/z 213.2, for quantification of levosulpiride and IS, respectively. The standard calibration curves showed good linearity within the range of 2-200 ng/mL (r(2) > or = 0.9990). The lower limit of quantitation was 2 ng/mL. The retention times of levosulpiride (0.63 min) and IS (0.66 min) presented a significant time saving benefit of the proposed method. No significant metabolic compounds were found to interfere with the analysis. This method offered good precision and accuracy and was successfully applied for the pharmacokinetic and bioequivalence study of a 25 mg of levosulpiride tablet in 24 healthy Korean volunteers. |
Databáze: | MEDLINE |
Externí odkaz: |